Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 12.48
-0.83 (-6.24%)
May 7, 2026, 4:08 PM HKT
HKG:2591 Market Cap
HKG:2591 has a market cap or net worth of 6.08 billion as of May 7, 2026.
Market Cap
6.08B
Enterprise Value
4.92B
Revenue
146.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.48
Market Cap Chart
Since August 15, 2025, HKG:2591's market cap has decreased from 26.15B to 6.08B, a decrease of -76.75%. That is a compound annual growth rate of -86.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 6.08B | -56.56% |
| Dec 31, 2025 | 14.00B | -46.48% |
| Aug 15, 2025 | 26.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alphamab Oncology | 9.83B |
| Shanghai Haohai Biological Technology | 9.41B |
| Lepu Biopharma | 9.08B |
| Shanghai Bao Pharmaceuticals | 8.48B |
| Abbisko Cayman | 8.42B |
| CK Life Sciences Int'l., (Holdings) | 7.11B |
| Ocumension Therapeutics | 5.94B |
| Laekna | 5.80B |